Skip to main content

Advertisement

SpringerLink
Log in

Premenstrual dysphoric disorder: out of the appendix

  • Published:
Archives of Women's Mental Health Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Borenstein JE, Dean BB, Yonkers KA, Endicott J (2007) Using the daily record of severity of problems as a screening instrument for premenstrual syndrome. Obstet Gynecol 109:1068–1075

    PubMed  Google Scholar 

  • Cunningham J, Yonkers KA, O’Brien S, Eriksson E (2009) Update on research and treatment of premenstrual dysphoric disorder. Harv Rev Psychiatry 17:120–137

    Article  PubMed  Google Scholar 

  • Halbreich U, O’Brien PM, Eriksson E, Backstrom T, Yonkers KA, Freeman EW (2006) Are there differential symptom profiles that improve in response to different pharmacological treatments of premenstrual syndrome/premenstrual dysphoric disorder? CNS Drugs 20:523–547

    Article  CAS  PubMed  Google Scholar 

  • Payne JL, Palmer JT, Joffe H (2009) A reproductive subtype of depression: conceptualizing models and moving toward etiology. Harv Rev Psychiatry 17:72–86

    Article  PubMed  Google Scholar 

  • Pearlstein T, Steiner M (2008) Premenstrual dysphoric disorder: burden of illness and treatment update. J Psychiatry Neurosci 33:291–301

    PubMed  Google Scholar 

  • Steiner M, Macdougall M, Brown E (2003) The premenstrual symptoms screening tool (PSST) for clinicians. Arch Womens Ment Health 6:203–209

    Article  CAS  PubMed  Google Scholar 

  • Steiner M, Pearlstein T, Cohen LS, Endicott J, Kornstein SG, Roberts C, Roberts DL, Yonkers K (2006) Expert guidelines for the treatment of severe PMS, PMDD, and comorbidities: the role of SSRIs. J Womens Health 15:57–69

    Article  Google Scholar 

  • Wittchen HU, Becker E, Lieb R, Krause P (2002) Prevalence, incidence and stability of premenstrual dysphoric disorder in the community. Psychol Med 32:119–132

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest

The author declares that she receives grant support from Pfizer and has served as a consultant for Teva.

Author information

Authors and Affiliations

  1. Department of Psychiatry and Human Behavior, Alpert Medical School of Brown University, Providence, RI, 02912, USA

    Teri Pearlstein

  2. Center for Women’s Behavioral Health, Women and Infants Hospital, 101 Dudley Street, Providence, RI, 02905, USA

    Teri Pearlstein

Authors
  1. Teri Pearlstein
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Teri Pearlstein.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pearlstein, T. Premenstrual dysphoric disorder: out of the appendix. Arch Womens Ment Health 13, 21–23 (2010). https://doi.org/10.1007/s00737-009-0111-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00737-009-0111-4

Keywords

Search

Navigation